Novo Nordisk
NVO
#73
Rank
โ‚น20.124 T
Marketcap
โ‚น4,529
Share price
-0.22%
Change (1 day)
-50.06%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.797 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.21 Billion. In 2024 the company made an earning of โ‚น1.708 Trillion, an increase over its 2023 earnings that were of โ‚น1.390 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น1.797 T5.22%
2024 โ‚น1.708 T22.84%
2023 โ‚น1.390 T57.81%
2022 โ‚น881.14 B5.24%
2021 โ‚น837.30 B12.38%
2020 โ‚น745.05 B13.11%
2019 โ‚น658.70 B-3.45%
2018 โ‚น682.24 B1.88%
2017 โ‚น669.63 B4.3%
2016 โ‚น642.00 B10.32%
2015 โ‚น581.93 B7.47%
2014 โ‚น541.50 B3.4%
2013 โ‚น523.69 B19.09%
2012 โ‚น439.75 B15.58%
2011 โ‚น380.48 B16.58%
2010 โ‚น326.38 B25.66%
2009 โ‚น259.74 B10.68%
2008 โ‚น234.68 B55.82%
2007 โ‚น150.61 B7.02%
2006 โ‚น140.73 B19.05%
2005 โ‚น118.21 B10.55%
2004 โ‚น106.92 B
2002 โ‚น73.41 B-14.39%
2001 โ‚น85.74 B-52.82%
2000 โ‚น181.72 B250%
1999 โ‚น51.92 B31.21%
1998 โ‚น39.57 B34.31%
1997 โ‚น29.46 B11.46%
1996 โ‚น26.43 B9.03%
1995 โ‚น24.24 B-3.15%
1994 โ‚น25.03 B-0.67%
1993 โ‚น25.19 B45.38%
1992 โ‚น17.33 B-13.81%
1991 โ‚น20.10 B37.12%
1990 โ‚น14.66 B-0.79%
1989 โ‚น14.78 B26.2%
1988 โ‚น11.71 B24.97%
1987 โ‚น9.37 B-0.9%
1986 โ‚น9.45 B-7.78%
1985 โ‚น10.25 B24.87%
1984 โ‚น8.21 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.069 T-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.031 T 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น725.00 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น821.32 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France